MOLINA HEALTHCARE, INC. Income Taxes Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In millions) | |||||||||||||||||
| Federal | $ | 589 | $ | 1,582 | $ | 1,464 | |||||||||||
| Foreign | — | 7 | — | ||||||||||||||
| Total | $ | 589 | $ | 1,589 | $ | 1,464 | |||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In millions) | |||||||||||||||||
| Current: | |||||||||||||||||
| Federal | $ | 58 | $ | 298 | $ | 349 | |||||||||||
| State | 16 | 59 | 55 | ||||||||||||||
| Total current | 74 | 357 | 404 | ||||||||||||||
| Deferred: | |||||||||||||||||
| Federal | 39 | 47 | (28) | ||||||||||||||
| State | 4 | 6 | (3) | ||||||||||||||
| Total deferred | 43 | 53 | (31) | ||||||||||||||
| Total income tax expense (benefit) | |||||||||||||||||
| Federal | 97 | 345 | 321 | ||||||||||||||
| State | 20 | 65 | 52 | ||||||||||||||
| Total income tax expense (benefit) | $ | 117 | $ | 410 | $ | 373 | |||||||||||
| Year Ended December 31, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Income from continuing operations, before income tax expense | $ | 589 | $ | 1,589 | $ | 1,464 | |||||||||||||||||||||||||||||
| Tax provision at the U.S. federal statutory rate | 124 | 21.0 | % | 334 | 21.0 | % | 308 | 21.0 | % | ||||||||||||||||||||||||||
| Federal | |||||||||||||||||||||||||||||||||||
| Tax Credits | |||||||||||||||||||||||||||||||||||
| Transferable energy-related tax credits | (19) | (3.2) | — | — | — | — | |||||||||||||||||||||||||||||
| Nontaxable or nondeductible items | |||||||||||||||||||||||||||||||||||
| Nondeductible compensation | 1 | 0.2 | 17 | 1.1 | 20 | 1.4 | |||||||||||||||||||||||||||||
| Other nontaxable or nondeductible items | 4 | 0.7 | 4 | 0.3 | 5 | 0.3 | |||||||||||||||||||||||||||||
| Other | (9) | (1.6) | 3 | 0.2 | (1) | — | |||||||||||||||||||||||||||||
| Foreign tax effects | |||||||||||||||||||||||||||||||||||
| Puerto Rico | |||||||||||||||||||||||||||||||||||
Tax provision at Puerto Rico statutory rate(1) | — | — | 3 | 0.2 | — | — | |||||||||||||||||||||||||||||
| Changes in valuation allowances | — | — | (3) | (0.2) | — | — | |||||||||||||||||||||||||||||
State income taxes, net of federal benefit(2) | 16 | 2.7 | 52 | 3.2 | 41 | 2.8 | |||||||||||||||||||||||||||||
| Income tax expense | $ | 117 | 19.8 | % | $ | 410 | 25.8 | % | $ | 373 | 25.5 | % | |||||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In millions) | |||||||||||||||||
U.S. Federal (1) | $ | 237 | $ | 312 | $ | 357 | |||||||||||
| California | 15 | 28 | * | ||||||||||||||
Other (2) | 23 | 39 | 48 | ||||||||||||||
| Total U.S. State and Local | 38 | 67 | 48 | ||||||||||||||
| Total income taxes paid, net | $ | 275 | $ | 379 | $ | 405 | |||||||||||
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Accrued expenses and reserve liabilities | $ | 92 | $ | 99 | |||||||
| Deferred compensation | 16 | 9 | |||||||||
| Other accrued medical costs | 27 | 25 | |||||||||
| Net operating losses | 9 | 5 | |||||||||
| Lease liabilities | 66 | 79 | |||||||||
| Unrealized losses | — | 18 | |||||||||
| Fixed assets and intangibles | 28 | 32 | |||||||||
| Tax credit carryover | 5 | 5 | |||||||||
| Other | — | 6 | |||||||||
| Valuation allowance | (19) | (19) | |||||||||
| Total deferred income tax assets, net of valuation allowance | 224 | 259 | |||||||||
| Right-of-use assets | (16) | (26) | |||||||||
| Prepaid expenses | (30) | (26) | |||||||||
| Total deferred income tax liabilities | (46) | (52) | |||||||||
| Net deferred income tax asset | $ | 178 | $ | 207 | |||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In millions) | |||||||||||||||||
| Gross unrecognized tax benefits at beginning of period | $ | (5) | $ | (5) | $ | (5) | |||||||||||
| Settlements | 5 | — | — | ||||||||||||||
| Gross unrecognized tax benefits at end of period | $ | — | $ | (5) | $ | (5) | |||||||||||
Want the next MOLINA HEALTHCARE, INC. income taxes disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment MOLINA HEALTHCARE, INC.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 10, 2026 | Showing above |
| 2024 | Feb 11, 2025 | |
| 2023 | Feb 13, 2024 | |
| 2022 | Feb 13, 2023 | |
| 2021 | Feb 14, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 19, 2019 | |
| 2017 | Mar 1, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Feb 26, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.